Screener / SEC EDGAR /CIK 0000888491 /10-K filed Feb 9, 2026, compared with Feb 13, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Real estate · REIT

Omega Healthcare Investors Inc OHI

Compare with peers Embed
What it said it expected, against what it reported

No target with a reported result yet

Releases of the last 3 years

The numbers OHI said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
AFFO per share (company-defined)
Fiscal 2025 (ended Dec 31, 2025)
Given $2.95 to $3.01 release May 1, 2025
Raised $3.04 to $3.07 release Jul 31, 2025
Raised $3.08 to $3.10 release Oct 30, 2025
– No standard number
The company's words
We have accretively invested approximately $423 million year-to-date through April 30th and, as a result, we are increasing our 2025 AFFO guidance to be between $2.95 and $3.01 per share from our previous guidance of between $2.90 and $2.98 per share.” release May 1, 2025
We have accretively invested approximately $605 million year-to-date and, as a result, we are increasing our 2025 AFFO guidance again to now be between $3.04 and $3.07 per share, up from our prior guidance range of between $2.95 and $3.01 per share.” release Jul 31, 2025
We have accretively invested nearly $1 billion year-to-date and, as a result, we are increasing our 2025 AFFO guidance again to now be between $3.08 and $3.10 per share, up from our initial guidance range of between $2.90 and $2.98 per share.” release Oct 30, 2025
AFFO per share (company-defined)
Fiscal 2024 (ended Dec 31, 2024)
Given $2.70 to $2.80 release Feb 7, 2024
Raised $2.78 to $2.84 release Aug 1, 2024
Raised $2.84 to $2.86 release Oct 30, 2024
– No standard number
The company's words
As a result of this improving operating backdrop and the greater visibility into our financial performance, Omega is able to start providing annual AFFO guidance for the first time since the pandemic, and we expect our 2024 AFFO to be between $2.70 and $2.80 per share.” release Feb 7, 2024
As a result, we are increasing our 2024 AFFO guidance to be between $2.78 and $2.84 per share from our previous guidance of between $2.70 and $2.80 per share.” release Aug 1, 2024
As a result, we are again increasing our 2024 AFFO guidance to be between $2.84 and $2.86 per share from our previous guidance of between $2.78 and $2.84 per share.” release Oct 30, 2024

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-07), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/OHI/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.